HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Health Advocate.
- Who it may be relevant to
- Registry conditions: Liver Transplant; Complications, Pediatric ALL. Basic parameters: 18 years — 25 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The Health Advocate for Liver Transplant (HEAL-Tx) Transition of Care Pilot is a nonrandomized, open-label intervention pilot of a health advocate intervention aimed to assess feasibility and acceptability of integrating a Health Advocate onto the transplant team to help adolescents transition their care to adult transplant teams. Across studies, health advocate roles vary, and can include coordinating medical care treatment, facilitating financial assistance (e.g., taxi vouchers), and connecting patients to community resources, which can improve self-management, mitigate social risks, and lead to better communication between the healthcare system and the family. In this pilot, the investigators will adapt this intervention for adolescent/young adult liver transplant patients and measure acceptability and feasibility according to RE-AIM.
Interventions
- Behavioral Health Advocate
The Health Advocate intervention will include helping pediatric liver transplant recipients and their families address unmet household social needs (e.g., food insecurity), improve patient-provider communication, and enhance care coordination.
Primary outcome measures
- Changes in patient experience [Time frame: Baseline and 180 days]
Secondary outcome measures (3)
- Change in medication adherence using MLVI [Time frame: Baseline and 180 days]
- The quality of health advocate interactions with the participants, healthcare team, and community-based resources. [Time frame: 180 days]
- A qualitative assessment of patient and healthcare provider satisfaction with the Health Advocate intervention. [Time frame: 180 days]
Eligibility criteria
Inclusion criteria
- Patient has received a liver transplant >1 year ago
- Study team has screened patient and discussed with the primary transplant practitioner that patient may benefit from the Health Advocate program.
- Patient has an unmet social risk (e.g., food insecurity) or MLVI >/= 2.0.
- Patient will be transferred to adult transplant team in <6 months.
- Patient can read and write English or Spanish
- Patient is between 18-25 years old and can provide informed consent.
- Patient has a working phone and smart device capable of video and/or audio virtual visits via Zoom.
Exclusion criteria
- Patient has significant cognitive impairment.
- Does not meet age criteria
- Patient is a ward of the state.
- Non-English, non-Spanish speakers.
- Non-US residents.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Supportive care
Study locations
United States · 2 centers
- University of California San Francisco — San Francisco
- Children's Healthcare of Atlanta — Atlanta
Identifiers
NCT: NCT06386198 · 23-40699